Neuroscience
-
Stretch Receptors: How They Monitor and Respond Across the Body
ISLAMABAD, July 17 — When a patient feels full after a meal, the sensation does not begin in the stomach alone. It…
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Amyloid-Beta Plaques: How Alzheimer’s Forms and Blood Tests
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
Alzheimer’s Amyloid Hypothesis Receives Strongest Clinical Validation Yet
ISLAMABAD, July 14 — A decades-old theory about what drives Alzheimer’s disease has received its strongest clinical validation to date, as new…
-
Brain Imaging Shows 8% Lower Choline in Anxiety Patients
ISLAMABAD, July 10 — New brain imaging research has uncovered a measurable link between anxiety disorders and lower levels of key nutrients…
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
LONDON, July 10 — John Hardy, the British geneticist and neuroscientist who first proposed that amyloid-beta accumulation is the primary cause of…
-
Alzheimer’s Drug Lecanemab Slows Cognitive Decline 27% in Trial
MANILA, July 10 — For millions of families across Asia and around the world, the shadow of Alzheimer’s disease has long been…
-
Alois Alzheimer Identified Disease But Colleague Named It
BERLIN, July 8 — On the surface, the story of Alois Alzheimer is a straightforward tale of medical discovery. A German psychiatrist…
-
Alzheimer’s Research Breakthroughs Target Disease Progression in 2024
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Key Players in the Research: UCSF and Collaborators Behind the Study
SAN FRANCISCO, July 7 — A chemical compound found in virtually every car tyre on the road has been linked to biological…
-
Alzheimer’s Disease: A Progressive Neurodegenerative Disorder
WASHINGTON, July 7 — On the seventh floor of a downtown research institute, a neurologist pulls up a brain scan on a…
-
Alzheimer’s Cases in U.S. to Reach 13.8 Million by 2060
WASHINGTON, July 7 — The figure that matters: 6.7 million. That is the number of Americans aged 65 and older living with…
-
Researchers Use Vitamin B12 to Bypass Blood-Brain Barrier in Glioblastoma Fight
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
What’s Actually Driving Your Chronic Pain, From A Pain Psychologist
NEW YORK, June 28 — For nearly two decades, a psychologist who specializes in pain has been living with a reminder that…
-
Pain Psychologist’s Own Paralysis Led to New Understanding of Chronic Pain
Sixteen years ago, a psychologist who treats pain woke up unable to walk. Two discs in her back had extruded, pressing on…
-
Study Links Less Than 42 Minutes Daily Sunlight Exposure to Higher Dementia Risk
The latest study out of China, published in the journal General Psychiatry, lands in a country where nearly a million people already…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
New Study Reveals Long, Silent Buildup of Brain Changes Before Dementia Onset
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
Arginine Prevents Toxic Protein Clumps in Brains of Alzheimer’s Mice
TOKYO — The amino acid arginine, a compound cheap enough to be sold as a bodybuilding supplement, stopped toxic proteins from clumping…
-
Japanese Study Finds Arginine Supplement Slows Alzheimer’s Brain Damage in Mice
A cheap, widely available dietary supplement may have just given Alzheimer’s research a jolt. Japanese scientists report that arginine, a common amino…
-
Japanese Study Finds Common Amino Acid May Fight Alzheimer’s
A research team in Japan has published findings suggesting that arginine, a widely available and inexpensive amino acid, may reduce toxic protein…
-
Arginine May Slow Alzheimer’s Progression in Animal Studies
TOKYO, June 6, 2026 — infopulsetoday.com — Researchers in Japan have made a promising discovery in the fight against Alzheimer’s disease, reporting…
-
Scientists Find Molecular Switch Locking Alzheimer’s Inflammation On
LA JOLLA, June 5 — Researchers at Scripps Research have made a significant discovery in understanding the molecular mechanism behind the chronic…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds